Fix build errors (I hope)

Author: zmbc

docs/source/models/concept_models/vivarium_mncnh_portfolio/postpartum_hemoglobin_module/module_document.rst

@@ -51,11 +51,11 @@ Follow the steps below to model the postpartum hemoglobin module. Module inputs
 
 1. Determine if simulant survived labor and progressed to the postpartum period
 2. Among surviving simulants, assign hemoglobin exposure for the first six weeks after delivery equal to hemoglobin exposure at birth
-3. Shift hemoglobin exposures for incident cases of maternal hemorrhage according to the :ref:`maternal hemorrhage risk effects document <2023_risk_effect_maternal_hemorrhage>` effect on the first six weeks after the end of pregnancy
+3. Shift hemoglobin exposures for incident cases of postpartum hemorrhage according to the :ref:`postpartum hemorrhage risk effects document <2023_risk_effect_postpartum_hemorrhage>` effect on the first six weeks after the end of pregnancy
 4. Among surviving simulants, assign the hemoglobin exposure between 6 weeks and 9 months postpartum
    using the non-pregnant hemoglobin distribution (MEID 27596, GBD 2023 version mv_20250804_flash_regal_snake)
    and the *same* propensity that was used to assign the simulant their initial hemoglobin exposure.
-5. Shift hemoglobin exposures for incident cases of maternal hemorrhage according to the :ref:`maternal hemorrhage risk effects document <2023_risk_effect_maternal_hemorrhage>` effect on the period from 6 weeks to 9 months after the end of pregnancy
+5. Shift hemoglobin exposures for incident cases of postpartum hemorrhage according to the :ref:`postpartum hemorrhage risk effects document <2023_risk_effect_postpartum_hemorrhage>` effect on the period from 6 weeks to 9 months after the end of pregnancy
 
 .. list-table:: Module required inputs
   :header-rows: 1

docs/source/models/risk_effects/maternal_hemorrhage/gbd2023/index.rst

@@ -1,4 +1,4 @@
-.. _2023_risk_effect_maternal_hemorrhage:
+.. _2023_risk_effect_postpartum_hemorrhage:
 
 ..
   Section title decorators for this document:
@@ -105,7 +105,7 @@ Assumptions and Limitations
   The continuous curves could result in simulants moving between several anemia categories over the course of the postpartum period, which is not captured here.
   This also means that the (relatively arbitrary) choices of durations of these periods are impactful.
 - We currently apply the same hemoglobin shift for all incident postpartum hemorrhage cases, but in reality the hemoglobin shift likely differs by severity of postpartum hemorrhage (moderate vs severe), which is not captured here.
-  We may address this in the future based on our approach in the :ref:`previous postpartum hemorrhage effects model <2019_2021_risk_effect_postpartum_hemorrhage>`.
+  We may address this in the future based on our approach in the :ref:`previous maternal hemorrhage effects model <2019_2021_risk_effect_maternal_hemorrhage>`.
 - The GBD shift is derived from USA MarketScan data, which may not be generalizable to other locations.
   In particular, treatment in the USA may be more effective at mitigating the hemoglobin shift associated with postpartum hemorrhage than treatment in other locations, which could lead to an underestimation of the hemoglobin shift in locations with less effective treatment.
   Additionally, the USA has more access to ultrasound than our modeled locations which could lead to better prevention.